Furthermore, Belur Nagaraj et al. (2021) identified miR-181a as activator of Wnt/β-catenin signaling that drives stemness and chemoresistance in ovarian cancer via the inhibition of SFRP4. Here, SFRP4 is linked to ovarian carcinoma.